Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection

International Journal of Immunopathology and Pharmacology

Volumn 27, Issue 1, 2014, Pages 87-96

  Mousa, Nasser ^a   Eldars, W ^a   Eldegla, H ^a   Fouda, O ^a   Gad, Y ^a   Abousamra, N ^a   Elmasry, E ^a   Arafa, M ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Chronic hepatitis C; Cirrhosis; Cytokines; Occult HCV

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; RNA; SERUM ALBUMIN; CYTOKINE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTRANSAMINASEMIA; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER INJURY; MALE; OCCULT HEPATITIS C; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; RNA PURIFICATION; TH1 CELL; TH2 CELL; VIRUS INFECTION; CHRONIC HEPATITIS C; HISTOPATHOLOGY; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; PATHOLOGY; VIROLOGY;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER FUNCTION TESTS; MALE; RNA, VIRAL; TH1 CELLS; TH2 CELLS;

EID: 84900526298     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201402700111     Document Type: Article

References (29)

1. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000; 182(3):698-707.
2. Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol 2012; 18(23):2887-94.
3. Pardo, M., J. M. López-Alcorocho, E. Rodríguez-Iñigo, Castillo I, Carreño V. Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat 2007; 14:36-40.
4. Kempuraj D, Donelan J, Frydas S, et al. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int J Immunopathol Pharmacol 2004; 17:103-6. (Pubitemid 39572165)
5. Petrarca C, Frydas S, Donelan J, et al. A novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation. Int J Immunopathol Pharmacol 2005; 18:191-94. (Pubitemid 40825881)
6. Huang SH, Frydas S, Conti P, et al. Interleukin-17: a revisited study. Int J Immunopathol Pharmacol 2004; 17:1-4. (Pubitemid 39572181)
7. Gioia C, Horejsh D, Agrati C, Martini F, Capobianchi MR, Ippolito G, Poccia F. T-Cell response profiling to biological threat agents including the SARS coronavirus. Int J Immunopathol Pharmacol 2005; 18:525-30. (Pubitemid 41532367)
8. Lanzilli G, Falchetti R, Tricarico M, Ungheri D, Fuggetta MP. In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function. Int J Immunopathol Pharmacol 2005; 18:245-54.
9. Marinova S, Nenkov P, Markova R, Nikolaeva S, Kostadinova R, Mitov I, Vretenarska M. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int J Immunopathol Pharmacol 2005; 18:457-73.
10. Totaro R, Passacantando A, Russo T, Parzanese I, Rascente M, Marini C, Tonietti G, Carolei A. Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis. Int J Immunopathol Pharmacol 2005; 18:377-83. (Pubitemid 40825899)
11. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15:575-81. (Pubitemid 24353909)
12. Vecchiet J, Dalessandro M, Travasi F, et al. Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by anti-retroviral therapy. Int J Immunopathol Pharmacol 2003; 16:157-66. (Pubitemid 36850856)
13. Perrella A, Borgia G, Borrelli F, et al. TNF-alpha serum level elevations in chronic hepatitis C patients with diabetes mellitus. Int J Immunopathol Pharmacol 2005; 18:189-93.
14. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-93. (Pubitemid 26260021)
15. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32:884-92. (Pubitemid 24100056)
16. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339:237-8.
17. Yamaki K, Uchida H, Li X, Yanagisawa R, Takano H, Hayashi H, Mori Y, Yoshino S. Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice. Int J Immunopathol Pharmacol 2005; 18:133-44. (Pubitemid 40343466)
18. Shapiro S, Gershtein V, Elias N, Zuckerman E, Salman N, Lahat N. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV) infected patients: effects of interferon-alpha (IFN-alpha) treatment. Clin Exp Immunol 1998; 114:55-60. (Pubitemid 28442813)
19. Cribier B, Schmitt C, Rey D, Lang JM, Kirn A, Stoll-Keller F. Production of cytokines in patients infected by hepatitis C virus. J Med Virol 1998; 55:89-91. (Pubitemid 28221609)
20. Pham TNQ, Mercer SE, Michalak TI. Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles. J. Viral Hepat 2009;16, 547-56.
21. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215-29. (Pubitemid 40364823)
22. Abayli B, Canataroǧlu A, Akkiz H. Serum profile of T helper 1 and T helper 2 cytokines in patients with chronic hepatitis C virus infection. Turk J Gastroenterol 2003; 14(1):7-11. (Pubitemid 36569839)
23. Parronchi P, De Carli M, Manetti R, et al. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992; 149:2977-83.
24. McCaughan GW, Gorrell MD, Bishop GA, et al. Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance. Immunol Rev 2000; 174:172-91. (Pubitemid 30201388)
25. Kamal SM, Graham CS, He Q, et al. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responser in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis 2004; 189:1140-50. (Pubitemid 38457236)
26. Napoli J, Bishop A, McGuinness PH, Painter DM, McCaughan GW. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 1996; 24:759-65. (Pubitemid 26334270)
27. Nelson DR, Tu Z, Soldevila-Pico C, et al. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 2003; 38:859-68. (Pubitemid 37221669)
28. Wynn A. IL-13 effector functions. Annu Rev Immunol 2003; 21:425.
29. Sobue S, Nomura T, Ishikawa T, et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection. J. Gastroenterol 2001; 36:544-551. (Pubitemid 32791841)